Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock


You May Also Like

Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers

                                                                  NANOBIOTIX PARTNERS WITH WEILL CORNELL MEDICINE ON PRE-CLINICAL STUDIES TO EVALUATE THE IMPACT ...

Celsion Corporation to Present at Upcoming Investor Conferences

   LAWRENCEVILLE, N.J., March 12, 2018 (GLOBE NEWSWIRE) --  -- Celsion Corporation (NASDAQ: CLSN), an ...